Titer test: what it checks, the immune cutoffs and how to read your results

A titer test measures antibodies to one infection to show whether you are immune. Each common titer has its own cutoff, an equivocal result counts as not immune, a hepatitis B result depends on when it was drawn, and for measles, mumps and chickenpox a vaccine record outranks the lab result.

Reviewed by LifeFrom’s medical AIPublished November 20, 2026 · 9 min read
Ask AI about this pageChatGPTClaudePerplexity
The distinctions
  1. 01
    Your vaccine record outranks a later titer

    For measles, mumps and chickenpox, two documented doses count as immunity even if a later titer reads negative or equivocal, and the titer decides only for people without records. Rubella has one exception: a woman who could become pregnant and whose rubella IgG is not clearly positive gets one extra MMR dose (up to three in total), with no retest 1.

  2. 02
    For hepatitis B, timing decides what the number means

    An anti-HBs below 10 mIU/mL 1 to 2 months after the vaccine series means the series did not work. The same number years later usually means the antibody has faded in a person who is still protected 2.

A titer (spelled titre in British English) is a blood test for antibodies against one named infection. It answers one practical question: is this person already protected? Nursing programs and hospitals ask for one when vaccine records are missing. Prenatal care checks rubella. People who work with blood get a hepatitis B check after the vaccine series. The result comes back as a number, a label (positive, equivocal or negative) or both. The rule that matters most is about records. For measles, mumps and chickenpox, two documented vaccine doses outrank any later titer, so the titer decides only for people without records. For hepatitis B the number decides, but only if it was measured 1 to 2 months after the last dose.

What a titer measures

The word titer comes from an older lab method. The lab diluted serum step by step (1:2, 1:4, 1:8 and onward) and reported the weakest dilution that still reacted. A titer of 1:64 meant antibody could still be detected after a 64-fold dilution. Most labs now use automated antibody tests (ELISA or chemiluminescence immunoassays). They report a concentration in international units (IU/mL or mIU/mL; see lab units explained) or an index, a number where about 1.0 or above usually counts as positive. The report then turns the number into positive, equivocal or negative against a cutoff the lab sets.

Immunity titers look for IgG, the long-lasting antibody the body keeps after a vaccine or a past infection. IgM is the early antibody of a fresh infection, and clinicians order it when they think someone is ill now. A report showing positive IgG and no IgM means past immunity. Other reports use the word titer for different things. An ANA titer of 1:80 is an autoantibody screen, and as autoimmune antibody tests explained sets out, ANA is positive in about 1 in 3 healthy adults at 1:40 and about 1 in 20 at 1:160. An RPR titer tracks syphilis treatment, covered in STI test results explained.

What each titer checks and the line that counts as immune

InfectionWhat the lab measuresCounts as immuneA negative usually meansWatch for
MeaslesMeasles IgGPositive on the lab's testNot immune, unless you have two documented doses 1In a 1985 outbreak, students with neutralizing antibody (the kind that blocks the virus) above about 120 mIU/mL were protected against classic measles 4. Routine labs report an index instead.
MumpsMumps IgGPositive on the lab's testNot immune if you have no records; still counts as immune with two documented doses 1No antibody level reliably predicts mumps protection 1
Rubella (German measles)Rubella IgGPositive on the lab's test (often 10 IU/mL or higher) 5Not immuneA different virus from measles, despite the nickname. Women who could become pregnant follow a stricter rule 1
Chickenpox (varicella)Varicella IgGPositiveNot immune if never vaccinatedCommercial tests can miss immunity from the vaccine 3
Hepatitis BSurface antibody (anti-HBs)10 mIU/mL or higher 2Depends on how long ago the last dose wasAnti-HBs falls over time even when protection stays 2
Hepatitis ATotal hepatitis A antibodyPositiveNot immune; the vaccine is a two-dose series for people who need protection, such as travelers or people with liver diseaseTurns positive after either past infection or the vaccine
TetanusTetanus antitoxin IgG0.1 IU/mL or higher by ELISA 6Below the protective levelRarely ordered; vaccine records usually decide boosters

Who needs a titer test, and who doesn't

A titer test is worth having when its result will change a decision. The usual reasons:

  • Healthcare workers and nursing or medical students whose employer or program wants lab proof, or whose vaccine records are lost.
  • People planning a pregnancy, for rubella and chickenpox. Both vaccines are live and cannot be given during pregnancy 1 3.
  • Adults with no vaccine records, because of lost paperwork, adoption, or vaccination in another country.
  • Higher-risk groups after the hepatitis B series, tested 1 to 2 months after the last dose. These include healthcare and public-safety workers (such as police and firefighters), people on dialysis, people with HIV or another weakened immune system, sex partners of people with hepatitis B, and babies born to mothers with hepatitis B, who are tested at 9 to 12 months 2.
  • People about to start immunosuppressive treatment or have a transplant, since live vaccines will soon be off-limits.

A titer adds little for someone with two documented MMR doses and two documented varicella doses 1 3. It also adds little for a low-risk adult who finished the hepatitis B series and wants a reassurance check years later 2.

How to read titer results: positive, equivocal, negative

Label on the reportWhat it meansUsual next step
Positive, reactive or immuneAntibody is above the lab's cutoffUsually counts as immune to that infection. Keep the full report as proof, and check with your clinician or occupational health if an employer or program has its own rules.
Equivocal or indeterminateSome antibody, but below the cutoffWith no vaccine records, it counts as not immune and the usual step is the vaccine 1. With two documented MMR or varicella doses, no extra dose is needed, apart from the rubella rule below. Go over it with your clinician or occupational health.
Negative or non-reactiveNo antibody detected at the cutoffWith no records, the usual step is the vaccine, and no titer is needed afterwards for MMR or varicella 1 3. For hepatitis B, see the timing rules below. Go over it with your clinician or occupational health.

Each lab sets its own cutoff, so compare your number only with the range printed beside it on your own report (reference ranges explained covers why ranges differ, and how to read any lab result covers the basics of a report). Three things can make a titer misleading. Immunoglobulin or blood products received in the past few months carry someone else's antibody and can affect the result. Immunosuppressive drugs can weaken the response to a vaccine. A hepatitis B titer taken years after the series often reads low even in a protected person 2.

Documented age-appropriate vaccination supersedes the results of subsequent serologic testing.McLean HQ et al., ACIP recommendations on measles, rubella and mumps, MMWR 2013

ACIP, the Advisory Committee on Immunization Practices, is the panel that sets US vaccine guidance for the CDC, and its 2013 rules 1 put a written record above a later titer for measles and mumps. Rubella keeps one exception. A woman who could become pregnant and whose rubella IgG is not clearly positive is given one more MMR dose, up to three in total, and does not need a retest 1. Hepatitis B follows a different rule. There the anti-HBs number decides, as long as it is measured at the right time.

Free, no accountRead your blood testGot an immunity panel back with a mix of reactive, equivocal and IU/mL results? Read every line of it, free.Read my results

Hepatitis B titer (hepatitis B surface antibody)

The hepatitis B titer measures anti-HBs, the antibody against the virus's surface protein. An anti-HBs of 10 mIU/mL or higher after a complete vaccine series is the accepted marker of protection 2. A result printed as "QL reactive" comes from a qualitative test, which only reports whether the level is above or below the line. For anti-HBs, reactive means the level reached at least 10 mIU/mL. A quantitative anti-HBs test reports the number itself.

Hepatitis B surface antibody: example resultmIU/mL

6 mIU/mLBelow the line
Below 100–10Protected, 10 and above10–100
An anti-HBs of 6 mIU/mL is below the protective line of 10. Measured 1 to 2 months after a vaccine series, it means the series did not produce protection. Ask your clinician about a second series, and about HBsAg and anti-HBc tests, because a poor response can sometimes mean an existing hepatitis B infection. Measured years later, it usually means the antibody has faded while immune memory still protects. For healthcare workers in that situation ACIP advises one more dose and a retest, and it does not recommend routine boosters for healthy low-risk adults 2.
Cutoff: anti-HBs of 10 mIU/mL or higher after a complete series, ACIP 2018 2. Some labs print reactive or non-reactive instead of a number.

Tested 1 to 2 months after the final dose, an anti-HBs below 10 mIU/mL means the series did not produce protection. ACIP's next steps are a second complete series and another test 1 to 2 months after it. Anyone still below 10 after two series is tested for hepatitis B surface antigen (HBsAg, a piece of the virus that shows a current infection) and core antibody (anti-HBc, a sign of past infection), because a poor response can sometimes mean an existing infection 2.

Tested years later, a low hepatitis B surface antibody result usually means the antibody has faded. Among people vaccinated as infants, 15% to 50% have low or undetectable anti-HBs 5 to 15 years later, yet immune memory still protects them against illness and chronic infection, so ACIP does not recommend routine boosters for people with healthy immune systems 2. Healthcare workers with a documented series and a later low result get one extra dose and a retest 1 to 2 months later. They complete a second series only if anti-HBs stays below 10 2.

Anti-HBs often falls below 10 after infant vaccination, yet protection usually lasts
mIU/mLProtective line, 10 mIU/mLBefore2 months1 year3 years5 years10 years15 yearsBest time to test
Illustrative curve, not data from any one person; the values are made up to show the shape. The shape follows ACIP 2018: anti-HBs peaks soon after the series, and 15% to 50% of people vaccinated as infants have low or undetectable levels 5 to 15 years later while immune memory still protects them 2.

Anti-HBs alone cannot show whether hepatitis B protection came from the vaccine or from a past infection. The core antibody settles it, and the full three-marker pattern, including what reactive means on each line, is in viral blood tests explained.

The vaccine never turns anti-HBc positive, because vaccinated people make only anti-HBs.

LifeFrom, Hepatitis B core antibody (anti-HBc)

MMR titer: measles, mumps and rubella

Under the 2013 ACIP rules, any of four things counts as evidence of measles immunity: written proof of vaccination, a positive lab test, lab-confirmed past measles, or birth before 1957 1. Adults at higher risk, including healthcare workers, college students and international travelers, need two documented doses to count. Two documented doses are treated as lasting evidence of immunity, so adults who have them need no routine booster or titer 1. Someone with two documented doses who tests negative or equivocal for measles is still considered immune, and ACIP does not recommend a third dose 1. The one routine use of a third dose is in a mumps outbreak, for people the health department identifies as at increased risk 7.

97%effective against measles after two MMR dosesOne dose: 93% against measles and 97% against rubella. Two doses: 88% against mumps. Median vaccine effectiveness, ACIP 2013 1

Mumps is the hardest of the three to read. No antibody test reliably predicts mumps immunity, so with two documented doses a negative mumps IgG is not a reason for another dose, while without records a negative or equivocal result counts as not immune 1. Clinical labs widely use 10 IU/mL as the rubella IgG cutoff 5. US prenatal care checks rubella IgG early in pregnancy, because rubella in the first trimester can cause congenital rubella syndrome (deafness, cataracts and heart defects in the baby) 1. England stopped routine rubella screening in pregnancy in 2016, as rubella had become very rare in the UK. If you could become pregnant and your rubella IgG is not clearly positive, raise the extra-dose rule with your clinician before trying to conceive 1.

Chickenpox (varicella) titer

Evidence of chickenpox immunity includes any of these: two documented doses, a positive lab test, lab-confirmed disease, a clinician's diagnosis or confirmation of past chickenpox or shingles, or US birth before 1980. Birth year does not count for healthcare workers, pregnant women or immunocompromised people 3. Standard commercial varicella IgG tests are not sensitive enough to reliably detect antibody from the vaccine. For that reason ACIP advises against routine testing after vaccination, and a negative chickenpox titer after two documented doses is not a reason for more doses 3.

Test first or vaccinate?

For MMR, ACIP does not call for a blood test before vaccinating an adult who lacks evidence of immunity 1, so when protection is needed soon, vaccination can be quicker than testing first. For chickenpox, testing adults with an uncertain history often spares them the shots 3. Both are live vaccines and are not given in pregnancy or to people with a weakened immune system. Which route fits you is a decision to make with your clinician or occupational health.

Testing first is usually favored whenVaccinating without a test is often reasonable when
An employer or school requires lab proofYou have no records and need protection soon
You are planning a pregnancy or immunosuppressive treatmentA titer with no records behind it came back equivocal
A past infection is likely (chickenpox or hepatitis A in an adult), so a positive result would spare a vaccine seriesWaiting for a result would delay a vaccine you need before travel
You belong to a higher-risk group and have finished the hepatitis B seriesYou are a low-risk adult starting the hepatitis B series

How the test is done, cost and turnaround

A titer uses a standard blood draw from a vein. It needs no fasting and can be done at any time of day (fasting before a blood test covers which tests do need it). It is usually ordered by a clinician, occupational health or student health, either as single antibodies or as a panel covering MMR, varicella and hepatitis B. Results usually come back within 1 to 5 working days. Prices vary with the lab and the number of antibodies. Employers and programs that require proof often pay for the test. Keep the full lab report, because programs and employers want the printed result with the lab's name and reference range, and a summary is usually not enough. How to get your lab results covers getting a copy. If your panel came from Quest or Labcorp, how to read Quest results and how to read Labcorp results show where each line sits on the report.

Free, no accountDrop in your lab report and see every marker explained in plain words, placed on the body, against your lab's range. It's read on your device: nothing is uploaded and nothing is kept.
Citations
  1. McLean HQ, Fiebelkorn AP, Temte JL, Wallace GS. Prevention of Measles, Rubella, Congenital Rubella Syndrome, and Mumps, 2013: Summary Recommendations of the Advisory Committee on Immunization Practices (ACIP). MMWR Recomm Rep 2013;62(RR-4):1-34
  2. Schillie S, Vellozzi C, Reingold A, et al. Prevention of Hepatitis B Virus Infection in the United States: Recommendations of the Advisory Committee on Immunization Practices. MMWR Recomm Rep 2018;67(1):1-31
  3. Marin M, Guris D, Chaves SS, Schmid S, Seward JF. Prevention of Varicella: Recommendations of the Advisory Committee on Immunization Practices (ACIP). MMWR Recomm Rep 2007;56(RR-4):1-40
  4. Chen RT, Markowitz LE, Albrecht P, et al. Measles antibody: reevaluation of protective titers. J Infect Dis 1990;162(5):1036-1042
  5. Skendzel LP. Rubella immunity: defining the level of protective antibody. Am J Clin Pathol 1996;106(2):170-174
  6. World Health Organization. The immunological basis for immunization series, Module 3: Tetanus (Update 2018)
  7. Marin M, Marlow M, Moore KL, Patel M. Recommendation of the Advisory Committee on Immunization Practices for Use of a Third Dose of Mumps Virus-Containing Vaccine in Persons at Increased Risk for Mumps During an Outbreak. MMWR Morb Mortal Wkly Rep 2018;67(1):33-38
  8. Tanner MR, O'Shea JG, Byrd KM, et al. Antiretroviral Postexposure Prophylaxis After Sexual, Injection Drug Use, or Other Nonoccupational Exposure to HIV: CDC Recommendations, United States, 2025. MMWR Recomm Rep 2025;74(1):1-56

Educational context only, not medical advice or a diagnosis. Always discuss your results with a clinician.